Indian Vaccine Market Report and Outlook 2015 - 2019

1. Imarc Imarc www.imarcgroup.com Consulting Services Indian Vaccine Market Report and Forecast 2015-2019 Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

2. Imarc Imarc www.imarcgroup.com About IMARC Group The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Imarc Imarc www.imarcgroup.com Report Description and Highlights The Indian Vaccine Market: Current Market Trends and Future Prospects A new report expects the Indian vaccine market to grow at a CAGR of 15% in the coming years. The sustained growth of the Indian economy, a consequent rise in public and private healthcare expenditures, 25-30 million births every year and a strong growth in the market for adult vaccines are expected to be the main factors catalyzingthis growth. The market for vaccines in India shows immense potential. The country has not only been self-sufficient in meeting its domestic requirements but has also emerged as a leading global exporter of vaccines across the world. The Indian vaccine industry began as a network of state owned manufacturers supplying basic childhood vaccines to the national immunization programme. In recent decades, however, a number of privately owned firms have emerged which have completely transformed the industry landscape. Their biggest success factor is similar to the approach that has been followed by Indian generic pharmaceutical manufacturers. This model involved concerted efforts to develop vaccines for not only tropical neglected diseases, but also cheaper alternatives of vaccines that are already available in the West. Despite its recent growth, however, the Indian vaccine industry still has a number of challenges to address. The market remains small (currently accounts for less than 2% of the global market) and underpenetrated compared to the developed countries. The country also lags behind its global peers in terms of vaccine coverage with a significant number of lives lost due to vaccine preventable deaths. Nevertheless, despite these challenges the situation appears bright for vaccine manufacturers. The country has around 25-30 Million births each year. This coupled with the sustained growth of the Indian economy, a consequent rise in public and private healthcare expenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccine market to grow at a CAGR of over 15% during the coming years.

4. Imarc Imarc www.imarcgroup.com Report Description and Highlights IMARC’s new report entitled “Indian Vaccine Market Report and Forecast 2015-2019” provides an analytical and statistical insight into the Indian vaccine market. The study is an outcome of an intensive research on the Indian vaccine industry and draws upon a comprehensive analysis of every major vaccine in India. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine market in any form. Key VaccinesCoveredin the Report BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR,Rotavirus, HepatitisB, Pneumococcal,Meningococcal, Rabies,HPV Focus of the Analysis for Each Vaccine • • • • • Vaccine Overview and Epidemiology Historical and Current Market Trends Market Breakup by Prescriber Market Breakup by Public and Private Sector Market Outlook Table of Contents 1. Research Methodology and Market Definitions 2. Executive Summary 3. Indian Vaccine Market 3.1 Introduction and History 3.2 Current and Historical Market Trends

5. Imarc Imarc www.imarcgroup.com Indian Vaccine Market

6. Imarc Imarc www.imarcgroup.com Report Description and Highlights 3.3 Market Breakup by Segment 3.4 Market Breakup by Key Players 3.5 Market Drivers and Challenges 3.6 Market Outlook 4. Market Analysis of Various Monovalent and Combined Vaccines 4.1 BCG Vaccine Market 4.1.1 Vaccine Overview and Epidemiology 4.1.2 Historical and Current Market Trends 4.1.3 Market Breakup by Prescriber 4.1.4 Market Breakup by Public and Private Sectors 4.1.5 Market Outlook 4.2 HIB Vaccine Market 4.2.1 Vaccine Overview and Epidemiology 4.2.2 Historical and Current Market Trends 4.2.3 Market Breakup by Prescriber 4.2.4 Market Breakup by Public and Private Sectors 4.2.5 Market Outlook 4.3 Influenza Vaccine Market 4.3.1 Vaccine Overview and Epidemiology 4.3.2 Historical and Current Market Trends 4.3.3 Market Breakup by Prescriber 4.3.4 Market Breakup by Public and Private Sectors 4.3.5 Market Outlook 4.4 Varicella Vaccine Market 4.4.1 Vaccine Overview and Epidemiology

7. Imarc Imarc www.imarcgroup.com Report Description and Highlights 4.4.2 Historical and Current Market Trends 4.4.3 Market Breakup by Prescriber 4.4.4 Market Breakup by Public and Private Sectors 4.4.5 Market Outlook 4.5 Typhoid Vaccine Market 4.5.1 Vaccine Overview and Epidemiology 4.5.2 Historical and Current Market Trends 4.5.3 Market Breakup by Prescriber 4.5.4 Market Breakup by Public and Private Sectors 4.5.5 Market Outlook 4.6 Japanese Encephalitis Vaccine Market 4.6.1 Vaccine Overview and Epidemiology 4.6.2 Historical and Current Market Trends 4.6.3 Market Breakup by Prescriber 4.6.4 Market Breakup by Public and Private Sectors 4.6.5 Market Outlook 4.7 Measles Vaccine Market 4.7.1 Vaccine Overview and Epidemiology 4.7.2 Historical and Current Market Trends 4.7.3 Market Breakup by Prescriber 4.7.4 Market Breakup by Public and Private Sectors 4.7.5 Market Outlook 4.8 Tetanus Toxoid Vaccine Market 4.8.1 Vaccine Overview and Epidemiology 4.8.2 Historical and Current Market Trends

8. Imarc Imarc www.imarcgroup.com Report Description and Highlights 4.8.3 Market Breakup by Prescriber 4.8.4 Market Breakup by Public and Private Sectors 4.8.5 Market Outlook 4.9 Hepatitis A Vaccine Market 4.9.1 Vaccine Overview and Epidemiology 4.9.2 Historical and Current Market Trends 4.9.3 Market Breakup by Prescriber 4.9.4 Market Breakup by Public and Private Sectors 4.9.5 Market Outlook 4.10 Rubella Vaccine Market 4.10.1 Vaccine Overview and Epidemiology 4.10.2 Historical and Current Market Trends 4.10.3 Market Breakup by Prescriber 4.10.4 Market Breakup by Public and Private Sectors 4.10.5 Market Outlook 4.11 DPT Vaccine Market 4.11.1 Vaccine Overview and Epidemiology 4.11.2 Historical and Current Market Trends 4.11.3 Market Breakup by Prescriber 4.11.4 Market Breakup by Public and Private Sectors 4.11.5 Market Outlook 4.12 Polio Vaccine Market 4.12.1 Vaccine Overview and Epidemiology 4.12.2 Historical and Current Market Trends 4.12.3 Market Breakup by Prescriber

9. Imarc Imarc www.imarcgroup.com Report Description and Highlights 4.12.4 Market Breakup by Public and Private Sectors 4.12.5 Market Outlook 4.13 MMR Vaccine Market 4.13.1 Vaccine Overview and Epidemiology 4.13.2 Historical and Current Market Trends 4.13.3 Market Breakup by Prescriber 4.13.4 Market Breakup by Public and Private Sectors 4.13.5 Market Outlook 4.14 Rotavirus Vaccine Market 4.14.1 Vaccine Overview and Epidemiology 4.14.2 Historical and Current Market Trends 4.14.3 Market Breakup by Prescriber 4.14.4 Market Breakup by Public and Private Sectors 4.14.5 Market Outlook 4.15 Hepatitis B Vaccine Market 4.15.1 Vaccine Overview and Epidemiology 4.15.2 Historical and Current Market Trends 4.15.3 Market Breakup by Prescriber 4.15.4 Market Breakup by Public and Private Sectors 4.15.5 Market Outlook 4.16 Pneumococcal Vaccine Market 4.16.1 Vaccine Overview and Epidemiology 4.16.2 Historical and Current Market Trends 4.16.3 Market Breakup by Prescriber 4.16.4 Market Breakup by Public and Private Sectors

10. Imarc Imarc www.imarcgroup.com Report Description and Highlights 4.16.5 Market Outlook 4.17 Meningococcal Vaccine Market 4.17.1 Vaccine Overview and Epidemiology 4.17.2 Historical and Current Market Trends 4.17.3 Market Breakup by Prescriber 4.17.4 Market Breakup by Public and Private Sectors 4.17.5 Market Outlook 4.18 Rabies Vaccine Market 4.18.1 Vaccine Overview and Epidemiology 4.18.2 Historical and Current Market Trends 4.18.3 Market Breakup by Prescriber 4.18.4 Market Breakup by Public and Private Sectors 4.18.5 Market Outlook 4.19 HPV Vaccine Market 4.19.1 Vaccine Overview and Epidemiology 4.19.2 Historical and Current Market Trends 4.19.3 Market Breakup by Prescriber 4.19.4 Market Breakup by Public and Private Sectors 4.19.5 Market Outlook 5. Regulatory Framework

11. Imarc Imarc www.imarcgroup.com Report Description and Highlights List of Figures Figure 1: Vaccine Development and Introduction in Indian Vaccine Market Figure 2: Comparison of Global Vaccine Market and Indian Vaccine Market Figure 3: India: Vaccine Market: Sales Value (in Billion INR), 2007 - 2014 Figure 4: India: Vaccine Market: Healthcare and Immunization Budget (In Billion INR), 2007 - 2014 Figure 5: India: Vaccine Market: Standard Procedure of Introducing New Vaccine Figure 6: India: Vaccine Market: Spending by Different Organizations on Polio Program Figure 7: India: Vaccine Market: Vaccine Coverage in Uttar Pradesh and Tamil Nadu Figure 8: India: Vaccine Market: Value Breakup by Therapies (in %), 2014 Figure 9: India: Monovalent Vaccine Market: Value Breakup by Vaccine (in %), 2014 Figure 10: India: Combined Vaccine Market: Value Breakup by Vaccine (in %), 2014 Figure 11: India: Vaccine Market: Value Breakup by Key Players (in %), 2014 Figure 12: India: BCG Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 13: India: BCG Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 14: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 15: India: BCG Vaccine Market: Breakup by Sector (in %), 2014 Figure 16: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 17: India: BCG Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 18: India: HIB Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 19: India: HIB Vaccine Market: Doses Administered (in ‘000), 2007 - 2014 Figure 20: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 21: India: HIB Vaccine Market: Breakup by Sector (in %), 2014 Figure 22: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 23: India: HIB Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 24: India: Influenza Vaccine Market: Sales value (in Million INR), 2010 - 2014

12. Imarc Imarc www.imarcgroup.com Report Description and Highlights Figure 25: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2014 Figure 26: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 27: India: Influenza Vaccine Market: Breakup by Sector (in %), 2014 Figure 28: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 29: India: Influenza Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 30: India: Varicella Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 31: India: Varicella Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 32: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 33: India: Varicella Vaccine Market: Breakup by Sector (in %), 2014 Figure 34: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 35: India: Varicella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 36: India: Typhoid Vaccine Market: Sales value (in Million INR), 2007 - 2014 Figure 37: India: Typhoid Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 38: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 39: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2014 Figure 40: India: Typhoid Vaccine Market: Sales Value Forecast (in Millions INR), 2015 - 2019 Figure 41: India: Typhoid Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 42: India: JE Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 43: India: JE Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 44: India: JE Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 45: India: JE Vaccine Market: Breakup by Sector (in %), 2014 Figure 46: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 47: India: JE Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 48: India: Measles Vaccine Market: Sales Value (in Million INR), 2007 – 2014 Figure 49: India: Measles Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 50: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2014

13. Imarc Imarc www.imarcgroup.com Report Description and Highlights Figure 51: India: Measles Vaccine Market: Breakup by Sector (in %), 2014 Figure 52: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 53: India: Measles Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 54: India: TT Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 55: India: TT Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 56: India: TT Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 57: India: TT Vaccine Market: Breakup by Sector (in %), 2014 Figure 58: India: TT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 59: India: TT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 60: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 61: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 62: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 63: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2014 Figure 64: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 65: India: Hepatitis A Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 66: India: Rubella Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 67: India: Rubella Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 68: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 69: India: Rubella Vaccine Market: Breakup by Sector (in %), 2014 Figure 70: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2015 – 2019 Figure 71: India: Rubella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 72: India: DPT Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 73: India: DPT Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 74: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 75: India: DPT Vaccine Market: Breakup by Sector (in %), 2014 Figure 76: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019

14. Imarc Imarc www.imarcgroup.com Report Description and Highlights Figure 77: India: DPT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 78: India: Polio Vaccine: Incidence of Polio, 2007 - 2014 Figure 79: India: Polio Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 80: India: Polio Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 81: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 82: India: Polio Vaccine Market: Breakup by Sector (in %), 2014 Figure 83: India: Polio Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 84: India: Polio Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 85: India: MMR Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 86: India: MMR Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 87: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 88: India: MMR Vaccine Market: Breakup by Sector (in %), 2014 Figure 89: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2015 - 2019 Figure 90: India: MMR Vaccine Market: Doses Administered Forecast (In Million), 2015 - 2019 Figure 91: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010-2014 Figure 92: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010-2014 Figure 93: India: Rotavirus Vaccine Market: Breakup by Prescriber (In %), 2014 Figure 94: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2014 Figure 95: India: Rotavirus Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 96: India: Rotavirus Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 97: India: Hepatitis B Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 98: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 99: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 100: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2014 Figure 101: India: Hepatitis B Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 102: India: Hepatitis B Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019

15. Imarc Imarc www.imarcgroup.com Report Description and Highlights Figure 103: India: Pneumonia Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 104: India: Pneumonia Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 105: India: Pneumonia Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 106: India: Pneumonia Vaccine Market: Breakup by Sector (in %), 2014 Figure 107: India: Pneumonia Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 108: India: Pneumonia Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 109: India: Meningococcal Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 110: India: Meningococcal Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 111: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 112: India: Polio Vaccine Market: Breakup by Sector (in %), 2014 Figure 113: India: Meningococcal Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 114: India: Meningococcal Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 115: India: Rabies Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 116: India: Rabies Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 117: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 118: India: Polio Vaccine Market: Breakup by Sector (in %), 2014 Figure 119: India: Rabies Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 120: India: Rabies Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 121: India: HPV Vaccine Market: Sales Value (in Million INR), 2007 - 2014 Figure 122: India: HPV Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 123: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2014 Figure 124: India: HPV Vaccine Market: Breakup by Sector (in %), 2014 Figure 125: India: HPV Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019 Figure 126: India: HPV Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019

16. Imarc Imarc www.imarcgroup.com Report Description and Highlights List of Tables Table 1: India: Vaccine Market Overview Table 2: India: Monovalent Vaccine Market: Value Breakup by Vaccine, 2014 and 2019 Table 3: India: Combined Vaccine Market: Value Breakup by Vaccine, 2014 and 2019 Table 4: India: Vaccine Market: Structural Barriers Table 5: India: BCG Vaccine: Overview Table 6: India: BCG Vaccine: Incidence of TB, 2013 Table 7: India: HIB Vaccine: Overview Table 8: India: HIB Vaccine: Incidence of HIB, 2006 and 2013 Table 9: India: Influenza Vaccine: Overview Table 10: India: Influenza Vaccine: Incidence of Influenza, 2011 and 2013 Table 11: India: Varicella Vaccine: Overview Table 12: India: Varicella Vaccine: Incidence of Chickenpox, 2013 Table 13: India: Typhoid Vaccine: Overview Table 14: India: Typhoid Vaccine: Incidence of Typhoid, 2013 Table 15: India: JE Vaccine: Overview Table 16: India: JE Vaccine: Incidence of JE, 2012 and 2013 Table 17: India: Measles Vaccine: Overview Table 18: India: Measles Vaccine: Incidence, 2007 - 2013 Table 19: India: Tetanus Toxoid Vaccine: Overview Table 20: India: Tetanus Toxoid Vaccine: Incidence of Tetanus Toxoid, 2007 – 2013 Table 21: India: Hepatitis A Vaccine: Overview Table 22: India: Hepatitis A Vaccine: Incidence of Hepatitis A, 2012 and 2013

17. Imarc Imarc www.imarcgroup.com Report Description and Highlights Table 23: India: Rubella Vaccine: Overview Table 24: India: Rubella Vaccine: Incidence of Rubella Table 25: India: DPT Vaccine: Overview Table 26: India: DPT Vaccine: Incidence of DPT, 2007 - 2013 Table 27: India: Polio Vaccine: Overview Table 28: India: MMR Vaccine: Overview Table 29: India: MMR Vaccine: Incidence of Measles, Mumps & Rubella, 2011 and 2013 Table 30: India: Rotavirus Vaccine: Overview Table 31: India: Rotavirus Vaccine: Incidence of Rotavirus, 2013 Table 32: India: Hepatitis B Vaccine: Overview Table 33: India: Hepatitis B Vaccine: Incidence of Hepatitis B, 2011 and 2014 Table 34: India: Pneumonia Vaccine: Overview Table 35: India: Pneumonia Vaccine: Incidence of Pneumonia, 2012 and 2013 Table 36: India: Meningococcal Vaccine: Overview Table 37: India: Meningococcal Vaccine: Incidence of Meningococcal, 2007 and 2013 Table 38: India: Rabies Vaccine: Overview Table 39: India: Rabies Vaccine: Incidence of Rabies, 2013 Table 40: India: HPV Vaccine: Overview Table 41: India: HPV Vaccine: Incidence of HPV, 2007 and 2014

18. Imarc Imarc www.imarcgroup.com Report Description and Highlights To buy the complete report or to get a free sample, please contact: IMARC Group Asia: Email: apac@imarcgroup.com Phone: +91-120-415-5099 IMARC Group North America: Email: america@imarcgroup.com Phone: +1-631-791-1145 IMARC Group Europe, Middle East & Africa: Email: ema@imarcgroup.com Phone: +44-702-409-7331 To know more please visit: http://www.imarcgroup.com/indian-vaccine-market

19. Imarc Imarc www.imarcgroup.com Report Description and Highlights © 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

20. Imarc Imarc www.imarcgroup.com FOR MORE DETAILS Visit us at : http://www.imarcgroup.com Stay With Us: TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com